Literature DB >> 6349202

Study of A- and B-cell function in beta-thalassemia major.

M Maioli, A Pacifico, T Frulio, M Longinotti.   

Abstract

Hepatic and pancreatic damage owing to iron overload is often present in patients with beta-thalassemia major. In order to investigate B-cell function and hepatic insulin clearance in these patients, under a high transfusion program and regular chelation therapy, we studied the glucose (BG), insulin (IRI) and C-peptide (CPR) response and the CPR/IRI ratio after OGTT in 27 patients with Cooley's anemia and in 10 sex- age- and weight-matched healthy subjects; we also studied BG and IRI levels after IVGTT in 9 beta-thalassemic patients and in 9 control subjects. Furthermore, BG, CPR, IRI and glucagon (IRG) response to arginine infusion were evaluated in 5 thalassemic patients with normal OGTT and in 5 age-, sex- and weight-matched normal children, in order to assess pancreatic A-cell function, too. OGTT and IVGTT were normal in the patients with beta-thalassemia major. Plasma IRI level 30 min after an oral glucose load and the insulinogenic index for cumulative intervals were significantly lower in thalassemics after OGTT, whereas the insulin response and insulinogenic index were normal following i.v. glucose. No significant difference was observed for the CPR/IRI ratio during OGTT between thalassemics and normal subjects. Finally, BG, CPR, IRI and IRG levels were similar in the thalassemic patients and in healthy children both fasting and following arginine infusion. Our data suggest that patients with beta-thalassemia major, under a high transfusion program and regular chelation therapy, may have normal glucose tolerance and normal hepatic insulin clearance in spite of iron overload in pancreas and liver. Insulin response to oral glucose was lower than the one to IVGTT, probably because of diminished secretion of the gastrointestinal hormones which stimulate insulin release.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349202     DOI: 10.1007/bf02624915

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  26 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  Endocrinopathy in thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

3.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

4.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

5.  Studies on the diabetic syndrome of idiopathic haemochromatosis.

Authors:  G Pozza; A Ghidoni
Journal:  Diabetologia       Date:  1968-03       Impact factor: 10.122

6.  C-peptide and insulin in liver disease.

Authors:  D G Johnston; G M Alberti; R Wright; G Smith-Laing; A M Stewart; S Sherlock; O Faber; C Binder
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

7.  Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.

Authors:  K Zuppinger; B Molinari; A Hirt; P Imbach; E Gugler; O Tönz; R P Zurbrügg
Journal:  Helv Paediatr Acta       Date:  1979

8.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

9.  An anomaly of insulin removal in perfused livers of obese-hyperglycemic (ob/ob) mice.

Authors:  C Karakash; F Assimacopoulos-Jeannet; B Jeanrenaud
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

10.  Glucagon secretion in acute and chronic pancreatitis.

Authors:  M Donowitz; R Hendler; H M Spiro; H J Binder; P Felig
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.